Tumors or cancer of the URINARY BLADDER.
A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.
A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
Pathological processes of the URINARY BLADDER.
Stones in the URINARY BLADDER; also known as vesical calculi, bladder stones, or cystoliths.
The epithelial lining of the URINARY TRACT.
Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
Blocked urine flow through the bladder neck, the narrow internal urethral opening at the base of the URINARY BLADDER. Narrowing or strictures of the URETHRA can be congenital or acquired. It is often observed in males with enlarged PROSTATE glands.
Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
A substituted carcinogenic nitrosamine.
Discharge of URINE, liquid waste processed by the KIDNEY, from the body.
The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Endoscopic examination, therapy or surgery of the urinary bladder.
Involuntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE.
Passage of a CATHETER into the URINARY BLADDER or kidney.
Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed)
Inability to empty the URINARY BLADDER with voiding (URINATION).
Used for excision of the urinary bladder.
The mechanical laws of fluid dynamics as they apply to urine transport.
A species of the true toads, Bufonidae, becoming fairly common in the southern United States and almost pantropical. The secretions from the skin glands of this species are very toxic to animals.
The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.
Presence of blood in the urine.
Low-density crystals or stones in any part of the URINARY TRACT. Their chemical compositions often include CALCIUM OXALATE, magnesium ammonium phosphate (struvite), CYSTINE, or URIC ACID.
A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
An abnormal passage in the URINARY BLADDER or between the bladder and any surrounding organ.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Long-term transplantability and morphological stability of three experimentally induced urinary bladder carcinomas in rats. (1/4713)

Three transitional cell carcinomas induced in Fischer 344 rats by a methylcholanthrene pellet or a foreign body inserted locally into the bladder have been serially transplanted in the syngeneic strain for up to 6.5 years. There have been no changes in the individual morphological characteristics of the tumors during this time. Cells cultured in vitro for varying numbers of passages reproduce regularly the morphology of each tumor when they are injected back into the animals and results from a microcytotoxicity assay for cellular immunity indicate that they retain a common, bladder tumor-specific antigen. These tumors are useful for research in turmo biology and are offered to other scientists seeking transplantable carcinomas for experimentation.  (+info)

Natural history of papillary lesions of the urinary bladder in schistosomiasis. (2/4713)

Variable epithelial hyperplasia was observed in urinary bladder of nine capuchin monkeys (Cebus apella) when examined at cystotomy 94 to 164 weeks after infection with Schistosoma haematobium. These hosts were followed for 24 to 136 weeks postcystotomy to determine the status of bladder lesions in relation to duration of infection and to ascertain whether lesion samples removed at cystotomy reestablished themselves in autologous and heterologous transfers. There was involution of urothelial hyperplasia in eight of nine animals and no evidence for establishment of transplanted bladder lesions.  (+info)

Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. (3/4713)

The evolution of alterations on chromosome 9, including the putative tumor suppressor genes mapped to the 9p21-22 region (the MTS genes), was studied in relation to the progression of human urinary bladder neoplasia by using whole organ superimposed histologic and genetic mapping in cystectomy specimens and was verified in urinary bladder tumors of various pathogenetic subsets with longterm follow-up. The applicability of chromosome 9 allelic losses as non-invasive markers of urothelial neoplasia was tested on voided urine and/or bladder washings of patients with urinary bladder cancer. Although sequential multiple hits in the MTS locus were documented in the development of intraurothelial precursor lesions, the MTS genes do not seem to represent a major target for p21-23 deletions in bladder cancer. Two additional tumor suppressor genes involved in bladder neoplasia located distally and proximally to the MTS locus within p22-23 and p11-13 regions respectively were identified. Several distinct putative tumor suppressor gene loci within the q12-13, q21-22, and q34 regions were identified on the q arm. In particular, the pericentromeric q12-13 area may contain the critical tumor suppressor gene or genes for the development of early urothelial neoplasia. Allelic losses of chromosome 9 were associated with expansion of the abnormal urothelial clone which frequently involved large areas of urinary bladder mucosa. These losses could be found in a high proportion of urothelial tumors and in voided urine or bladder washing samples of nearly all patients with urinary bladder carcinoma.  (+info)

Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer. (4/4713)

Recent studies have shown that patients whose bladder cancer exhibit overexpression of RB protein as measured by immunohistochemical analysis do equally poorly as those with loss of RB function. We hypothesized that loss of p16 protein function could be related to RB overexpression, since p16 can induce transcriptional downregulation of RB and its loss may lead to aberrant RB regulation. Conversely, loss of RB function has been associated with high p16 protein expression in several other tumor types. In the present study RB negative bladder tumors also exhibited strong nuclear p16 staining while each tumor with strong, homogeneous RB nuclear staining were p16 negative, supporting our hypothesis. To expand on these immunohistochemical studies additional cases were selected in which the status of the p16 encoding gene had been determined at the molecular level. Absent p16 and high RB protein expression was found in the tumors having loss of heterozygosity within 9p21 and a structural change (mutation or deletion) of the remaining p16 encoding gene allele, confirming the staining results. These results strongly support the hypothesis that the RB nuclear overexpression recently associated with poor prognosis in bladder cancer is also associated with loss of p16 function and implies that loss of p16 function could be equally deleterious as RB loss in bladder and likely other cancers.  (+info)

Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop. (5/4713)

The Mdm2 protein is frequently overexpressed in human non-seminomatous germ cell tumours and transitional carcinoma of the bladder where it may contribute to tolerance of wtp53. Mdm2 forms an autoregulatory feedback loop with p53; the Mdm2 gene is responsive to transactivation by p53 and once synthesized the Mdm2 protein terminates the p53 response. We show here that the topoisomerase poison etoposide, like ultra violet irradiation, inhibits Mdm2 synthesis. Cytotoxic concentrations of etoposide (IC90 for > 3 h) result in inhibition of Mdm2 induction at both the RNA and protein level. Rapid apoptosis ensues. Global transcription is not inhibited: p21waf-1/cip1 and GADD45 expression increase in a dose dependent manner. Inhibition of Mdm2 synthesis depends on the continuous presence of etoposide, suggesting the DNA damage may prevent transcription. Downregulation of Mdm2 transcript occurs in cells expressing HPV16-E6 suggesting that inhibition of Mdm2 transcription is p53-independent. When cells are -treated with a pulse (1 h) of etoposide and reincubated in drug free medium, Mdm2 synthesis commences immediately after damage is repaired (3 h) and the p53 response is attenuated. Induction of apoptosis and loss of clonogenicity are 3-5-fold lower under pulse treatment conditions. This is the first observation of inhibition of Mdm2 transcription following treatment with topoisomerase (topo II) poisons, a feature that may be useful in tumour types where p53 is tolerated by overexpression of Mdm2.  (+info)

Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site. (6/4713)

Interleukin (IL)-10 is a potent immunosuppressive cytokine that has been found to be present at the tumor site in a wide variety of human cancers, including transitional cell carcinoma of the bladder. Using a murine bladder tumor (MB49), which we show to express the male transplantation antigen (HY), we tested the hypothesis that IL-10 at the tumor site can block the generation of a tumor-specific type 1 immune response. We show that, despite its expression of HY, MB49 fails to prime for an HY-specific type 1 (IFN-gamma) response in normal female mice. Although MB49 does not constitutively produce IL-10, our data support a model whereby MB49 induces infiltrating cells to produce IL-10. This feature rendered the IL-10 knockout (KO) mouse, whose infiltrating cells are incapable of IL-10 production, a suitable model in which to study MB49 in the absence of IL-10. When injected into IL-10 KO mice, MB49 does prime for an HY-specific, type 1 immune response. Furthermore, IL-10 KO mice show prolonged survival and an increased capacity to reject tumors as compared with normal mice. We also tested the ability of tumor-induced IL-10 to inhibit immunization to a non-tumor antigen present at the tumor site. When vaccinia virus encoding beta-galactosidase (beta-gal) is injected into the tumors of normal mice, no beta-gal-specific IFN-gamma response is mounted. However, when this same viral construct is injected into the tumors of IL-10 KO mice, it produces a strong beta-gal-specific, IFN-gamma response. These studies demonstrate that tumor-induced IL-10 can block the generation of a tumor-specific type 1 immune response as well as subvert attempts to elicit a type 1 immune response to a non-tumor antigen at the tumor site.  (+info)

Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. (7/4713)

Epidermal growth factor receptor (EGFR) regulates the growth and progression of human transitional cell carcinoma (TCC) of the bladder. We have shown that therapy targeting EGFR inhibited the growth of human TCC established orthotopically in nude mice. The purpose of this study was to evaluate whether EGFR-directed therapy affects angiogenesis associated with the growth and metastasis of human TCC. We determined the cytostatic effect and the effect on production of angiogenic factors after in vitro treatment of the human TCC cell line 253J B-V with MAb C225, a chimerized monoclonal anti-EGFR antibody. The 253J B-V cells were implanted orthotopically into athymic nude mice, and established tumors (4 weeks) were treated with i.p. MAb C225. Expression of the angiogenic factors vascular endothelial growth factor (VEGF), interleukin-8 (IL-8), and basic fibroblast growth factor (bFGF) was evaluated by immunohistochemistry and in situ mRNA hybridization analyses and correlated with microvessel density evaluated after immunohistochemical staining with anti-CD31. In vitro treatment with MAb C225 inhibited mRNA and protein production of VEGF, IL-8, and bFGF by 253J B-V cells in a dose-dependent manner. MAb C225 therapy of nude mice with established TCCs growing orthotopically resulted in inhibition of growth and metastasis compared with controls (P <0.0005). VEGF, IL-8, and bFGF expression was significantly lower in treated tumors than in controls. The down-regulation of these angiogenic factors preceded the involution of blood vessels. These studies indicate that therapy with anti-EGFR MAb C225 has a significant antitumor effect mediated, in part, by inhibition of angiogenesis.  (+info)

Vaginal epithelioid angiosarcoma. (8/4713)

A case of epithelioid angiosarcoma of the vagina is described. Only five cases of angiosarcoma at this site have been reported, three of which followed radiotherapy for other gynaecological malignancies. None is described as an epithelioid angiosarcoma, an unusual and recently described variant which is readily confused with carcinoma. This is thought to be the first reported epithelioid angiosarcoma at this site and highlights the difficulties in diagnosis.  (+info)

Urinary Bladder Neoplasms are abnormal growths or tumors in the urinary bladder, which can be benign (non-cancerous) or malignant (cancerous). Malignant neoplasms can be further classified into various types of bladder cancer, such as urothelial carcinoma, squamous cell carcinoma, and adenocarcinoma. These malignant tumors often invade surrounding tissues and organs, potentially spreading to other parts of the body (metastasis), which can lead to serious health consequences if not detected and treated promptly and effectively.

The urinary bladder is a muscular, hollow organ in the pelvis that stores urine before it is released from the body. It expands as it fills with urine and contracts when emptying. The typical adult bladder can hold between 400 to 600 milliliters of urine for about 2-5 hours before the urge to urinate occurs. The wall of the bladder contains several layers, including a mucous membrane, a layer of smooth muscle (detrusor muscle), and an outer fibrous adventitia. The muscles of the bladder neck and urethra remain contracted to prevent leakage of urine during filling, and they relax during voiding to allow the urine to flow out through the urethra.

Transitional cell carcinoma (TCC) is a type of cancer that develops in the transitional epithelium, which is the tissue that lines the inner surface of the urinary tract. This includes the renal pelvis, ureters, bladder, and urethra. Transitional cell carcinoma is the most common type of bladder cancer and can also occur in other parts of the urinary system.

Transitional cells are specialized epithelial cells that can stretch and change shape as the organs they line expand or contract. These cells normally have a flat, squamous appearance when at rest but become more cuboidal and columnar when the organ is full. Transitional cell carcinomas typically start in the urothelium, which is the innermost lining of the urinary tract.

Transitional cell carcinoma can be classified as non-invasive (also called papillary or superficial), invasive, or both. Non-invasive TCCs are confined to the urothelium and have not grown into the underlying connective tissue. Invasive TCCs have grown through the urothelium and invaded the lamina propria (a layer of connective tissue beneath the urothelium) or the muscle wall of the bladder.

Transitional cell carcinoma can also be categorized as low-grade or high-grade, depending on how abnormal the cancer cells look under a microscope and how likely they are to grow and spread. Low-grade TCCs tend to have a better prognosis than high-grade TCCs.

Treatment for transitional cell carcinoma depends on the stage and grade of the cancer, as well as other factors such as the patient's overall health. Treatment options may include surgery, radiation therapy, chemotherapy, or immunotherapy.

Urinary bladder diseases refer to a range of conditions that affect the urinary bladder, a muscular sac located in the pelvis that stores urine before it is excreted from the body. These diseases can impair the bladder's ability to store or empty urine properly, leading to various symptoms and complications. Here are some common urinary bladder diseases with their medical definitions:

1. Cystitis: This is an inflammation of the bladder, often caused by bacterial infections (known as UTI - Urinary Tract Infection). However, it can also be triggered by irritants, radiation therapy, or chemical exposure.
2. Overactive Bladder (OAB): A group of symptoms that include urgency, frequency, and, in some cases, urge incontinence. The bladder muscle contracts excessively, causing a strong, sudden desire to urinate.
3. Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): A chronic bladder condition characterized by pain, pressure, or discomfort in the bladder and pelvic region, often accompanied by urinary frequency and urgency. Unlike cystitis, IC/BPS is not caused by infection, but its exact cause remains unknown.
4. Bladder Cancer: The abnormal growth of cancerous cells within the bladder lining or muscle. It can present as non-muscle-invasive (superficial) or muscle-invasive, depending on whether the tumor has grown into the bladder muscle.
5. Bladder Diverticula: Small sac-like pouches that form in the bladder lining and protrude outward through its wall. These may result from increased bladder pressure due to conditions like OAB or an enlarged prostate.
6. Neurogenic Bladder: A condition where nerve damage or dysfunction affects the bladder's ability to store or empty urine properly. This can lead to symptoms such as incontinence, urgency, and retention.
7. Benign Prostatic Hyperplasia (BPH): Although not a bladder disease itself, BPH is a common condition in older men where the prostate gland enlarges, putting pressure on the bladder and urethra, leading to urinary symptoms like frequency, urgency, and hesitancy.

Understanding these various bladder conditions can help individuals identify potential issues early on and seek appropriate medical attention for proper diagnosis and treatment.

Urinary bladder calculi, also known as bladder stones, refer to the formation of solid mineral deposits within the urinary bladder. These calculi develop when urine becomes concentrated, allowing minerals to crystallize and stick together, forming a stone. Bladder stones can vary in size, ranging from tiny sand-like particles to larger ones that can occupy a significant portion of the bladder's volume.

Bladder stones typically form as a result of underlying urinary tract issues, such as bladder infection, enlarged prostate, nerve damage, or urinary retention. Symptoms may include lower abdominal pain, difficulty urinating, frequent urination, blood in the urine, and sudden, strong urges to urinate. If left untreated, bladder stones can lead to complications like urinary tract infections and kidney damage. Treatment usually involves surgical removal of the stones or using other minimally invasive procedures to break them up and remove the fragments.

Urothelium is the specialized type of epithelial tissue that lines the urinary tract, including the renal pelvis, ureters, bladder, and urethra. It is a type of transitional epithelium that can change its shape and size depending on the degree of distension or stretching of the organs it lines.

The main function of urothelium is to provide a barrier against urine, which contains various waste products and potential irritants, while also allowing the exchange of ions and water. The urothelial cells are joined together by tight junctions that prevent the passage of substances through the paracellular space, and they also have the ability to transport ions and water through their cell membranes.

In addition to its barrier function, urothelium is also involved in sensory and immune functions. It contains specialized nerve endings that can detect mechanical and chemical stimuli, such as stretch or irritation, and it expresses various antimicrobial peptides and other defense mechanisms that help protect the urinary tract from infection.

Overall, urothelium plays a critical role in maintaining the health and function of the urinary tract, and its dysfunction has been implicated in various urinary tract disorders, such as interstitial cystitis/bladder pain syndrome and bladder cancer.

Overactive bladder (OAB) is a urological condition characterized by the involuntary contraction of the detrusor muscle of the urinary bladder, leading to symptoms such as urgency, frequency, and nocturia (the need to wake up at night to urinate), with or without urge incontinence (the involuntary loss of urine associated with a strong desire to void). It is important to note that OAB is not necessarily related to bladder volume or age-related changes, and it can significantly impact an individual's quality of life. The exact cause of OAB is not fully understood, but it may be associated with neurological disorders, certain medications, infections, or other underlying medical conditions. Treatment options for OAB include behavioral modifications, pelvic floor exercises, bladder training, medications, and, in some cases, surgical interventions.

Cystitis is a medical term that refers to inflammation of the bladder, usually caused by a bacterial infection. The infection can occur when bacteria from the digestive tract or skin enter the urinary tract through the urethra and travel up to the bladder. This condition is more common in women than men due to their shorter urethras, which makes it easier for bacteria to reach the bladder.

Symptoms of cystitis may include a strong, frequent, or urgent need to urinate, pain or burning during urination, cloudy or strong-smelling urine, and discomfort in the lower abdomen or back. In some cases, there may be blood in the urine, fever, chills, or nausea and vomiting.

Cystitis can usually be treated with antibiotics to kill the bacteria causing the infection. Drinking plenty of water to flush out the bacteria and alleviating symptoms with over-the-counter pain medications may also help. Preventive measures include practicing good hygiene, wiping from front to back after using the toilet, urinating after sexual activity, and avoiding using douches or perfumes in the genital area.

Urinary bladder neck obstruction is a medical condition that refers to a partial or complete blockage at the bladder neck, which is the area where the bladder connects to the urethra. This obstruction can be caused by various factors such as prostate enlargement, bladder tumors, scar tissue, or nerve damage.

The bladder neck obstruction can lead to difficulty in urinating, a weak urine stream, and the need to strain while urinating. In severe cases, it can cause urinary retention, kidney failure, and other complications. Treatment for this condition depends on the underlying cause and may include medications, surgery, or minimally invasive procedures.

Neurogenic bladder is a term used to describe bladder dysfunction due to neurological damage or disease. The condition can result in problems with bladder storage and emptying, leading to symptoms such as urinary frequency, urgency, hesitancy, incontinence, and retention.

Neurogenic bladder can occur due to various medical conditions, including spinal cord injury, multiple sclerosis, Parkinson's disease, diabetic neuropathy, and stroke. The damage to the nerves that control bladder function can result in overactivity or underactivity of the bladder muscle, leading to urinary symptoms.

Management of neurogenic bladder typically involves a multidisciplinary approach, including medications, bladder training, catheterization, and surgery in some cases. The specific treatment plan depends on the underlying cause of the condition and the severity of the symptoms.

Butylhydroxybutylnitrosamine (OH-BBN or BBN) is a chemical compound that is primarily used in laboratory research as a potent carcinogenic agent. It is known to induce tumors in various organs, particularly in the urinary bladder and liver, when administered to experimental animals.

The IUPAC name for Butylhydroxybutylnitrosamine is N-butyl-N-(4-hydroxybutyl)nitrosamine. Its molecular formula is C8H19NO3. It is a white to off-white crystalline powder, soluble in water and alcohol.

It is important to note that Butylhydroxybutylnitrosamine is not used in human medicine or therapy due to its carcinogenic properties. Its use is restricted to research purposes only, under controlled conditions and with appropriate safety measures in place.

Urination, also known as micturition, is the physiological process of excreting urine from the urinary bladder through the urethra. It is a complex process that involves several systems in the body, including the urinary system, nervous system, and muscular system.

In medical terms, urination is defined as the voluntary or involuntary discharge of urine from the urethra, which is the final pathway for the elimination of waste products from the body. The process is regulated by a complex interplay between the detrusor muscle of the bladder, the internal and external sphincters of the urethra, and the nervous system.

During urination, the detrusor muscle contracts, causing the bladder to empty, while the sphincters relax to allow the urine to flow through the urethra and out of the body. The nervous system plays a crucial role in coordinating these actions, with sensory receptors in the bladder sending signals to the brain when it is time to urinate.

Urination is essential for maintaining the balance of fluids and electrolytes in the body, as well as eliminating waste products such as urea, creatinine, and other metabolic byproducts. Abnormalities in urination can indicate underlying medical conditions, such as urinary tract infections, bladder dysfunction, or neurological disorders.

The urinary tract is a system in the body responsible for producing, storing, and eliminating urine. It includes two kidneys, two ureters, the bladder, and the urethra. The kidneys filter waste and excess fluids from the blood to produce urine, which then travels down the ureters into the bladder. When the bladder is full, urine is released through the urethra during urination. Any part of this system can become infected or inflamed, leading to conditions such as urinary tract infections (UTIs) or kidney stones.

Urinary Tract Infections (UTIs) are defined as the presence of pathogenic microorganisms, typically bacteria, in any part of the urinary system, which includes the kidneys, ureters, bladder, and urethra, resulting in infection and inflammation. The majority of UTIs are caused by Escherichia coli (E. coli) bacteria, but other organisms such as Klebsiella, Proteus, Staphylococcus saprophyticus, and Enterococcus can also cause UTIs.

UTIs can be classified into two types based on the location of the infection:

1. Lower UTI or bladder infection (cystitis): This type of UTI affects the bladder and urethra. Symptoms may include a frequent and urgent need to urinate, pain or burning during urination, cloudy or strong-smelling urine, and discomfort in the lower abdomen or back.

2. Upper UTI or kidney infection (pyelonephritis): This type of UTI affects the kidneys and can be more severe than a bladder infection. Symptoms may include fever, chills, nausea, vomiting, and pain in the flanks or back.

UTIs are more common in women than men due to their shorter urethra, which makes it easier for bacteria to reach the bladder. Other risk factors for UTIs include sexual activity, use of diaphragms or spermicides, urinary catheterization, diabetes, and weakened immune systems.

UTIs are typically diagnosed through a urinalysis and urine culture to identify the causative organism and determine the appropriate antibiotic treatment. In some cases, imaging studies such as ultrasound or CT scan may be necessary to evaluate for any underlying abnormalities in the urinary tract.

Cystoscopy is a medical procedure that involves the insertion of a thin, flexible tube with a camera and light on the end (cystoscope) into the bladder through the urethra. This procedure allows healthcare professionals to examine the lining of the bladder and urethra for any abnormalities such as inflammation, tumors, or stones. Cystoscopy can be used for diagnostic purposes, as well as for therapeutic interventions like removing small bladder tumors or performing biopsies. It is typically performed under local or general anesthesia to minimize discomfort and pain.

Urinary incontinence is defined as the involuntary loss or leakage of urine that is sufficient to be a social or hygienic problem. It can occur due to various reasons such as weak pelvic muscles, damage to nerves that control the bladder, certain medications, and underlying medical conditions like diabetes, multiple sclerosis, or Parkinson's disease.

There are different types of urinary incontinence, including stress incontinence (leakage of urine during physical activities like coughing, sneezing, or exercising), urge incontinence (a sudden and strong need to urinate that results in leakage), overflow incontinence (constant dribbling of urine due to a bladder that doesn't empty completely), functional incontinence (inability to reach the bathroom in time due to physical or mental impairments), and mixed incontinence (a combination of any two or more types of incontinence).

Urinary incontinence can significantly impact a person's quality of life, causing embarrassment, social isolation, and depression. However, it is a treatable condition, and various treatment options are available, including bladder training, pelvic floor exercises, medications, medical devices, and surgery.

Urinary catheterization is a medical procedure in which a flexible tube (catheter) is inserted into the bladder through the urethra to drain urine. This may be done to manage urinary retention, monitor urine output, or obtain a urine sample for laboratory testing. It can be performed as a clean, intermittent catheterization, or with an indwelling catheter (also known as Foley catheter) that remains in place for a longer period of time. The procedure should be performed using sterile technique to reduce the risk of urinary tract infection.

Smooth muscle, also known as involuntary muscle, is a type of muscle that is controlled by the autonomic nervous system and functions without conscious effort. These muscles are found in the walls of hollow organs such as the stomach, intestines, bladder, and blood vessels, as well as in the eyes, skin, and other areas of the body.

Smooth muscle fibers are shorter and narrower than skeletal muscle fibers and do not have striations or sarcomeres, which give skeletal muscle its striped appearance. Smooth muscle is controlled by the autonomic nervous system through the release of neurotransmitters such as acetylcholine and norepinephrine, which bind to receptors on the smooth muscle cells and cause them to contract or relax.

Smooth muscle plays an important role in many physiological processes, including digestion, circulation, respiration, and elimination. It can also contribute to various medical conditions, such as hypertension, gastrointestinal disorders, and genitourinary dysfunction, when it becomes overactive or underactive.

Urinary retention is a medical condition in which the bladder cannot empty completely or at all, resulting in the accumulation of urine in the bladder. This can lead to discomfort, pain, and difficulty in passing urine. Urinary retention can be acute (sudden onset) or chronic (long-term). Acute urinary retention is a medical emergency that requires immediate attention, while chronic urinary retention may be managed with medications or surgery. The causes of urinary retention include nerve damage, bladder muscle weakness, prostate gland enlargement, and side effects of certain medications.

Cystectomy is a surgical procedure in which all or part of the urinary bladder is removed. This procedure is often used to treat bladder cancer, but it may also be necessary in cases of severe bladder damage, infection, or inflammation that do not respond to other treatments.

There are several types of cystectomy, including:

1. Radical cystectomy: This is the most common type of cystectomy performed for bladder cancer. It involves removing the entire bladder, as well as nearby lymph nodes, the prostate gland in men, and the uterus, ovaries, fallopian tubes, and a portion of the vagina in women.
2. Partial cystectomy: In this procedure, only a part of the bladder is removed. This may be an option for patients with early-stage bladder cancer that has not spread deeply into the bladder muscle or to other parts of the body.
3. Urinary diversion: After a cystectomy, the surgeon must create a new way for urine to leave the body. This may involve creating a urostomy, in which a piece of intestine is used to form a stoma (an opening) on the abdominal wall, through which urine can be collected in a bag. Alternatively, the surgeon may create an internal pouch using a segment of intestine, which can then be connected to the ureters and allowed to drain into the rectum or vagina.

As with any surgical procedure, cystectomy carries risks such as bleeding, infection, and reactions to anesthesia. Patients may also experience long-term complications such as urinary incontinence, sexual dysfunction, and changes in bowel habits. However, for many patients with bladder cancer or other severe bladder conditions, cystectomy can be a life-saving procedure.

Urodynamics is a medical test that measures the function and performance of the lower urinary tract, which includes the bladder, urethra, and sphincters. It involves the use of specialized equipment to record measurements such as bladder pressure, urine flow rate, and residual urine volume. The test can help diagnose various urinary problems, including incontinence, urinary retention, and overactive bladder.

During the test, a small catheter is inserted into the bladder through the urethra to measure bladder pressure while filling it with sterile water or saline solution. Another catheter may be placed in the rectum to record abdominal pressure. The patient is then asked to urinate, and the flow rate and any leaks are recorded.

Urodynamics can help identify the underlying cause of urinary symptoms and guide treatment decisions. It is often recommended for patients with complex or persistent urinary problems that have not responded to initial treatments.

'Bufo marinus' is the scientific name for a species of toad commonly known as the Cane Toad or Giant Toad. This toad is native to Central and South America, but has been introduced to various parts of the world including Florida, Australia, and several Pacific islands. The toad produces a toxic secretion from glands on its back and neck, which can be harmful or fatal if ingested by pets or humans.

Intravesical administration refers to the instillation of medication directly into the bladder through a catheter or other medical device. This method is often used to deliver treatments for various bladder conditions, such as interstitial cystitis, bladder cancer, and chronic bladder infections. The medication is held in the bladder for a specified period, usually ranging from a few minutes to several hours, before being urinated out. This allows the medication to come into close contact with the bladder lining, potentially enhancing its effectiveness while minimizing systemic side effects.

Neoplasms are abnormal growths of cells or tissues in the body that serve no physiological function. They can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow growing and do not spread to other parts of the body, while malignant neoplasms are aggressive, invasive, and can metastasize to distant sites.

Neoplasms occur when there is a dysregulation in the normal process of cell division and differentiation, leading to uncontrolled growth and accumulation of cells. This can result from genetic mutations or other factors such as viral infections, environmental exposures, or hormonal imbalances.

Neoplasms can develop in any organ or tissue of the body and can cause various symptoms depending on their size, location, and type. Treatment options for neoplasms include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy, among others.

Urine is a physiological excretory product that is primarily composed of water, urea, and various ions (such as sodium, potassium, chloride, and others) that are the byproducts of protein metabolism. It also contains small amounts of other substances like uric acid, creatinine, ammonia, and various organic compounds. Urine is produced by the kidneys through a process called urination or micturition, where it is filtered from the blood and then stored in the bladder until it is excreted from the body through the urethra. The color, volume, and composition of urine can provide important diagnostic information about various medical conditions.

Hematuria is a medical term that refers to the presence of blood in urine. It can be visible to the naked eye, which is called gross hematuria, or detected only under a microscope, known as microscopic hematuria. The blood in urine may come from any site along the urinary tract, including the kidneys, ureters, bladder, or urethra. Hematuria can be a symptom of various medical conditions, such as urinary tract infections, kidney stones, kidney disease, or cancer of the urinary tract. It is essential to consult a healthcare professional if you notice blood in your urine to determine the underlying cause and receive appropriate treatment.

Urinary calculi, also known as kidney stones or nephrolithiasis, are hard deposits made of minerals and salts that form inside the urinary system. These calculi can develop in any part of the urinary system, which includes the kidneys, ureters, bladder, and urethra.

The formation of urinary calculi typically occurs when there is a concentration of certain substances, such as calcium, oxalate, uric acid, or struvite, in the urine. When these substances become highly concentrated, they can crystallize and form small seeds that gradually grow into larger stones over time.

The size of urinary calculi can vary from tiny, sand-like particles to large stones that can fill the entire renal pelvis. The symptoms associated with urinary calculi depend on the stone's size, location, and whether it is causing a blockage in the urinary tract. Common symptoms include severe pain in the flank, lower abdomen, or groin; nausea and vomiting; blood in the urine (hematuria); fever and chills; and frequent urge to urinate or painful urination.

Treatment for urinary calculi depends on the size and location of the stone, as well as the severity of symptoms. Small stones may pass spontaneously with increased fluid intake and pain management. Larger stones may require medical intervention, such as extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, or percutaneous nephrolithotomy (PCNL) to break up or remove the stone. Preventive measures include maintaining adequate hydration, modifying dietary habits, and taking medications to reduce the risk of stone formation.

Muscle contraction is the physiological process in which muscle fibers shorten and generate force, leading to movement or stability of a body part. This process involves the sliding filament theory where thick and thin filaments within the sarcomeres (the functional units of muscles) slide past each other, facilitated by the interaction between myosin heads and actin filaments. The energy required for this action is provided by the hydrolysis of adenosine triphosphate (ATP). Muscle contractions can be voluntary or involuntary, and they play a crucial role in various bodily functions such as locomotion, circulation, respiration, and posture maintenance.

A urinary bladder fistula is an abnormal connection or passage between the urinary bladder and another organ or structure, such as the skin, intestine, or vagina. This condition can result from various factors, including surgery, injury, infection, inflammation, radiation therapy, or malignancy.

Bladder fistulas may lead to symptoms like continuous leakage of urine through the skin, frequent urinary tract infections, and fecal matter in the urine (when the fistula involves the intestine). The diagnosis typically involves imaging tests, such as a CT scan or cystogram, while treatment often requires surgical repair of the fistula.

Pancreatic neoplasms refer to abnormal growths in the pancreas that can be benign or malignant. The pancreas is a gland located behind the stomach that produces hormones and digestive enzymes. Pancreatic neoplasms can interfere with the normal functioning of the pancreas, leading to various health complications.

Benign pancreatic neoplasms are non-cancerous growths that do not spread to other parts of the body. They are usually removed through surgery to prevent any potential complications, such as blocking the bile duct or causing pain.

Malignant pancreatic neoplasms, also known as pancreatic cancer, are cancerous growths that can invade and destroy surrounding tissues and organs. They can also spread (metastasize) to other parts of the body, such as the liver, lungs, or bones. Pancreatic cancer is often aggressive and difficult to treat, with a poor prognosis.

There are several types of pancreatic neoplasms, including adenocarcinomas, neuroendocrine tumors, solid pseudopapillary neoplasms, and cystic neoplasms. The specific type of neoplasm is determined through various diagnostic tests, such as imaging studies, biopsies, and blood tests. Treatment options depend on the type, stage, and location of the neoplasm, as well as the patient's overall health and preferences.

  • Because many urothelial carcinomas contain a minor squamous cell component, a diagnosis of squamous cell carcinoma of the bladder should be rendered only when the tumor is solely composed of a squamous cell component in the absence of a conventional urothelial carcinoma component. (medscape.com)
  • The cancer assays to be tested use DNA analysis and antibodies to specific proteins as well as functional assays for proteins to attempt to identify bladder tumor presence. (centerwatch.com)
  • The primary objective of this study is to evaluate the utility of emerging technologies in the detection of bladder tumor cells using non-invasive approaches utilizing voided urine samples. (centerwatch.com)
  • Imaging studies suggested a primary bladder tumor. (webpathology.com)
  • Most benign spindle cell tumors of the urinary bladder are an inflammatory myofibroblastic tumor (IMT). (medscape.com)
  • Microscopic findings of inflammatory myofibroblastic tumor of the bladder. (medscape.com)
  • Sarcomatoid carcinoma or carcinosarcoma (CS) is a rare neoplasm of the urinary bladder that is defined by the World Health Organization as a biphasic tumor consisting of malignant epithelial and mesenchymal components [1]. (pfeiffertheface.com)
  • The first case (65 years) was a male in whom follicular carcinoma of thyroid, metachronous neuroendocrine tumor of duodenum and urinary bladder transitional cell carcinoma were diagnosed within an eight-year period. (banglajol.info)
  • Urinary bladder Carcinoma Late recurrence Survival After. (karger.com)
  • Some people who are treated for bladder cancer never have a recurrence. (pfeiffertheface.com)
  • Although recurrence is not uncommon among people who are treated for bladder cancer, in many cases the recurrence can be treated effectively. (pfeiffertheface.com)
  • This type of chemo is used only for very early-stage bladder cancers. (pfeiffertheface.com)
  • Most bladder cancers are transitional cell (urothelial) cancers, but there are other types as well, including squamous cell carcinoma, adenocarcinoma, and small cell carcinoma. (pfeiffertheface.com)
  • There are convincing evidences that the exposure to tobacco smoke cancerogenes significantly increases the risk of many neoplasms including cancers of the larynx, mouth, upper throat, oesophagus, urinary bladder. (termedia.pl)
  • Tumors or cancer of the URINARY BLADDER. (reference.md)
  • [ 7 ] notably Sudan and Egypt, where squamous cell carcinoma ranges from two thirds to three quarters of all malignant tumors of the bladder. (medscape.com)
  • The rate of occurrence of these tumors is highest in the developed countries, ranking as the sixth most frequent neoplasm. (centerwatch.com)
  • Approximately 90% of malignant tumors arising in the bladder are of epithelial origin, the majority being transitional cell carcinomas. (centerwatch.com)
  • Early stage bladder tumors have been classified into two groups with distinct behaviors and different molecular profiles: Low-grade tumors (always papillary and usually superficial), and high-grade tumors (either papillary or non-papillary and often invasive). (centerwatch.com)
  • Clinically, superficial bladder tumors (stages Ta, Tis and T1) account for 75-80% of bladder neoplasms, while the remaining 15-20% are invasive (T2, T3, T4) or metastatic lesions at the time of presentation. (centerwatch.com)
  • In the last few years, it has become clear that activation events associated with FGFR-3 can be found associated with 40%-60% of low-grade, low-stage bladder tumors whilst p53 mutations are linked to a more aggressive phenotype progressing via the CIS pathway. (centerwatch.com)
  • According to the authors, the molecular characteristics and clinical behavior of pediatric bladder tumors are, with the exception of rhabdomyosarcoma, less well understood than those in adults. (medscape.com)
  • 11] The oldest large series of 38 spindle cell tumors in the urinary bladder included 17 pseudotumors, 4 postoperative spindle cell nodules (PSCNs), and 13 sarcomas. (medscape.com)
  • Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer. (musc.edu)
  • Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. (musc.edu)
  • Worldwide, the incidence of squamous cell carcinoma of the bladder varies. (medscape.com)
  • Cyclophosphamide chemotherapy has also been reported to increase the incidence of squamous cell carcinoma of the bladder. (medscape.com)
  • As previously mentioned, schistosomiasis is the major cause of squamous cell carcinoma of the bladder in African countries. (medscape.com)
  • PATIENT SUMMARY: Urothelial carcinoma of the bladder has distinct genomic features, which are different from distinct genomic features of urothelial carcinoma of the renal pelvis and/or ureter. (wustl.edu)
  • We investigated the expression of AR, ERα and ERβ in 188 bladder tumour specimens, as well as matched 141 non-neoplastic bladder and 14 lymph node metastasis tissues, by immunohistochemistry. (urotoday.com)
  • Most of the cervical epithelial neoplasms and their precursors occur at the squamocolumnar junction or within the transformation zone. (cytojournal.com)
  • Bladder pain syndrome Interstitial cystitis Magnetic resonance imagery Pelvic pain Urinary bladder The definition of Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC) was redefined. (karger.com)
  • A tubular soft tissue opaque structure with multiple stippled mineral opacities randomly distributed throughout (arrowheads) extends from the region of the urinary bladder and pelvic inlet, along the sagittal midline, ventral to the descending colon, and to the ventral aspect of the mid-abdominal area. (avma.org)
  • Pelvic lipomatosis is a rare disorder of increased fat tissue deposition within the spaces of the pelvis, causing extrinsic compression of the bladder, rectum, and blood vessels. (radiologytoday.net)
  • Approximately one-half of patients with symptomatic pelvic lipomatosis present with lower urinary symptoms, such as increased frequency, dysuria, nocturia, and hesitancy. (radiologytoday.net)
  • Radiation therapy is not only unsuccessful in treating pelvic lipomatosis, but can also result in bladder outlet and rectal strictures.2 Urinary diversion procedures consisting of ileal conduit, nephrostomy tube, or vesicostomy may be required in cases of severe outlet obstruction. (radiologytoday.net)
  • Squamous cell carcinoma of the urinary bladder is a malignant neoplasm derived from bladder urothelium with pure squamous phenotype. (medscape.com)
  • Urothelial carcinoma (UC) is one the most common malignancies derived from the urothelium of the lower urinary tract. (medsci.org)
  • A higher degree of adenocarcinoma has also been reported in schistosomal-associated bladder carcinomas. (medscape.com)
  • Delaying cystectomy (removal of the bladder) could lead to development of metastatic bladder cancer , which is lethal. (rxwiki.com)
  • Discuss with your doctor the relative risk of cystectomy versus the risk of metastatic bladder cancer. (rxwiki.com)
  • How long can you live with metastatic bladder cancer? (pfeiffertheface.com)
  • Patients who present with metastatic bladder cancer generally have a poor prognosis, surviving only very few months (1). (pfeiffertheface.com)
  • In cases that have gone on to cystoscopy and biopsy, there was often evidence of proliferative bladder mucosal changes including cystitis glandularis and cystitis cystica, although it is thought that these changes could also be related to chronic lymphatic obstruction due to the fat itself rather than chronic infection. (radiologytoday.net)
  • Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder. (ucsf.edu)
  • Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the rat. (ucsf.edu)
  • Neurogenic bladder and neurogenic bowels are both fairly common when damage in the nervous system affects these particular areas of the body. (urinaryhealthtalk.com)
  • Comparison of spinal cord contusion and transection: functional and histological changes in the rat urinary bladder. (ucsf.edu)
  • The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. (centerwatch.com)
  • Report prolonged irritable bladder symptoms or prolonged passage of red-colored urine immediately to your doctor. (rxwiki.com)
  • All five urine samples from bladder cancer patients and five healthy controls were successfully identified with the same sensor arrays. (dundee.ac.uk)
  • In other words, someone with MS who gets urge incontinence may have problems with their bladder or their bowels holding on to their urine or stool until its time to go. (urinaryhealthtalk.com)
  • Urinary volatile organic compounds (VOCs) are a promising alternative to cell-based biomarkers. (dundee.ac.uk)
  • Herein, we demonstrate a novel diagnostic platform based on an optic fluorescence sensor array for detecting urinary bladder cancer VOCs biomarkers. (dundee.ac.uk)
  • Canonical discriminant analysis (CDA) and partial least squares discriminant analysis (PLS-DA) was employed and correctly detected 31/48 urinary bladder cancer VOC biomarkers and achieved an overall 77.75% sensitivity and 93.25% specificity by PLS-DA modelling. (dundee.ac.uk)
  • The choice of VOCs for the initial part was based on an extensive systematic search of the literature and then followed up using urinary samples from patients with urinary bladder transitional cell carcinoma. (dundee.ac.uk)
  • Therefore, in context of diagnosis, prognosis, and therapy, a bacterial urinary tract infection (UTI) may be viewed as a secondary (or complicating) rather than a primary (or definitive) diagnostic entity. (ivis.org)
  • Overall, the experiments in this study describe a real-time platform for non-invasive bladder cancer diagnosis using fluorescence-based gassensor arrays. (dundee.ac.uk)
  • CT typically confirms the diagnosis by demonstrating a homogenous, unencapsulated low attenuation (fat density) mass within the pelvis displacing the bladder anteriorly and superiorly with resultant elongation of the bladder neck, giving it the characteristic pear shape. (radiologytoday.net)
  • Ultrasound may play a role in diagnosis, particularly 3D sonography, which can show the abnormal morphology of the bladder similar to CT and is useful in evaluating for ureteral obstruction and hydronephrosis. (radiologytoday.net)
  • In context of surgery, conceptual understanding of alterations in interactions between host defenses and pathogenic microbes that result in bacterial urinary tract infections (UTI) are important for at least two reasons. (ivis.org)
  • Right lateral (A) and ventrodorsal (B) abdominal radiographic images of a 9-year-old 7.0-kg (15.4-lb) spayed female Shih Tzu with a 1.5-year history of vaginal discharge, polyuria, polydipsia, and urinary tract infections. (avma.org)
  • The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer. (musc.edu)
  • Intravesical rAd-IFNa/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. (musc.edu)
  • For muscle-invasive bladder cancer, our doctors may recommend chemotherapy before surgery. (pfeiffertheface.com)
  • Large clinical studies have shown that this method improves cure rates and long-term survival for people with muscle-invasive bladder cancer. (pfeiffertheface.com)
  • Chemotherapy for invasive bladder cancer is nearly always a course of treatment, taking several months in total. (pfeiffertheface.com)
  • abstract = "CONTEXT: Bladder urothelial carcinoma (BUC) and upper tract urothelial carcinoma (UTUC) have genetic differences, which may influence therapy. (wustl.edu)
  • In the United States, squamous cell carcinoma constitutes around 2%-5% of all urinary bladder carcinomas. (medscape.com)
  • In certain parts of the African continent, the majority of bladder carcinomas are of the squamous cell type. (medscape.com)
  • Urothelial carcinomas (UCs) of the upper tract (UT) have an epidemiology similar to those of the bladder. (cytojournal.com)
  • The expression of androgen and/or oestrogen receptors has been assessed in bladder cancer, leading to conflicting data of expression levels and their relationship to histopathological characteristics of the tumours. (urotoday.com)
  • Primary upper urinary tract (UT) urothelial carcinoma (UC) is rare. (cytojournal.com)
  • The most common presenting symptom is hematuria, followed by bladder outlet obstruction and dysuria. (medscape.com)
  • The bladder in these cases has been given many descriptors, such as banana-, pear-, gourd-, or tear-shaped.1-4 Mild to severe ureteral obstruction can be seen in 17% to 45% of cases.4 Barium enema evaluation may show an elongated and straightened rectosigmoid colon, the so-called "tower rectum. (radiologytoday.net)
  • Smoking has a well-recognized role in the development of bladder carcinoma, with smoking duration and intensity directly related to an increased risk. (medscape.com)
  • However the presence of a high percentage of wild type variants in the higher stages of the disease suggest the existence of another pathway of molecular changes leading to the development of bladder cancer. (elis.sk)
  • It has been hypothesized that the abnormal fat accumulates as a response to chronic urinary tract infection. (radiologytoday.net)
  • To assess the expression of the androgen receptor (AR) and oestrogen receptors (ERs) in bladder tumours because recent studies have shown conflicting results and the prognostic significance of their expression remains unclear. (urotoday.com)
  • Racial differences in the risk of second primary bladder cancer following radiation therapy among localized prostate cancer patients. (musc.edu)
  • In one study from Egypt, 82% of patients with bladder carcinoma were found to harbor Schistosoma haematobium eggs in the bladder wall. (medscape.com)
  • Enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry (IHC) assay were performed to measure GOLPH3 expression in serum and tissue samples, respectively, of bladder cancer patients. (medscimonit.com)
  • ROC analysis showed that serum GOLPH3 exhibited a high diagnostic value to distinguish bladder cancer patients from healthy persons. (medscimonit.com)
  • GOLPH3 was highly expressed in bladder cancer patients and could be used as a diagnostic tool. (medscimonit.com)
  • The aim of the study was to assess the genetic diversity of bladder cancer and determine the suitability of a proposed molecular marker panel to monitor the course of bladder cancer patients. (elis.sk)
  • The study involved 185 patients with diagnosed bladder cancer. (elis.sk)
  • Multiple sclerosis patients can experience a variety of bladder problems, including nocturia, urinary urgency, incontinence, and urinary hesitancy. (urinaryhealthtalk.com)
  • Bowel dysfunction is also a common symptom for patients with MS. One study of 77 patients with clinically definite MS showed that bowel problems are not associated with bladder dysfunction, patient's age, degree of disability, or duration of disease. (urinaryhealthtalk.com)
  • Why is it Important to Recognize that Bacterial Urinary Tract Infection is not a Primary Diagnostic Entity? (ivis.org)
  • Previous publications from this Urology Department have introduced the idea of a non-invasive, molecular-based assay for the detection and monitoring of bladder cancer (Levesque et al. (centerwatch.com)
  • Non-invasive detection of urinary bladder cancer remains a significant challenge. (dundee.ac.uk)
  • Bladder cancer is one of the most common malignancies worldwide. (centerwatch.com)
  • Two cases of multiple primary malignancies (two or more neoplasms without any relationship between them) are presented in this paper. (banglajol.info)
  • Chemo for bladder cancer can be given in 2 different ways: Intravesical chemotherapy: For this treatment, the chemo drug is put directly into the bladder. (pfeiffertheface.com)
  • It is described in Intravesical therapy for bladder cancer. (pfeiffertheface.com)
  • Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: histologic and functional evaluation. (ucsf.edu)
  • We simultaneously analyze three receptors in non-neoplastic bladder tissues as well as in primary and metastatic bladder tumour specimens. (urotoday.com)
  • Urinary Bladder Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (musc.edu)
  • Compared to benign bladders, a significant decrease in the expression of AR, ERα or ERβ in bladder cancer was seen. (urotoday.com)